Evidence map›Paper›PMID 38567991›Full record

ArticleJournal of the American Chemical Society2024

Structure-Toxicity Relationship in Intermediate Fibrils from α-Synuclein Condensates.

Serene W Chen, Joseph D Barritt, Roberta Cascella, Alessandra Bigi, Cristina Cecchi, Martina Banchelli, Angelo Gallo, James A Jarvis, Fabrizio Chiti, Christopher M Dobson and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
12.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. The Structure of Human IAPP Fibrils Reflects Membrane and pH Conditions.Journal of the American Chemical Society · 2025
    Article
  16. Article
  17. Journal of the American Chemical Society · 2025
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 2 countries.

Serene W ChenDepartment of Life Sciences, Imperial College London, London SW7 2AZ, U.K.
Joseph D BarrittDepartment of Life Sciences, Imperial College London, London SW7 2AZ, U.K.ORCID 0000-0002-4311-5305
Roberta CascellaDepartment of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Florence 50134, Italy.ORCID 0000-0001-9856-6843
Alessandra BigiDepartment of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Florence 50134, Italy.ORCID 0000-0002-1067-6288
Cristina CecchiDepartment of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Florence 50134, Italy.ORCID 0000-0001-8387-7737
Martina BanchelliInstitute of Applied Physics "Nello Carrara" National Research Council of Italy, Sesto Fiorentino, Florence 50019, Italy.ORCID 0000-0001-5348-0552
Angelo GalloDepartment of Chemistry, University of Turin, Turin 10124, Italy.ORCID 0000-0001-9778-4822
James A JarvisDepartment of Life Sciences, Imperial College London, London SW7 2AZ, U.K.
Fabrizio ChitiDepartment of Experimental and Clinical Biomedical Sciences, Section of Biochemistry, University of Florence, Florence 50134, Italy.ORCID 0000-0002-1330-1289
Christopher M DobsonDepartment of Chemistry, University of Cambridge, Cambridge CB2 1EW, U.K.
Giuliana FuscoDepartment of Chemistry, University of Cambridge, Cambridge CB2 1EW, U.K.ORCID 0000-0002-3644-9809
Alfonso De SimoneDepartment of Life Sciences, Imperial College London, London SW7 2AZ, U.K.ORCID 0000-0001-8789-9546
University of Florence · ITImperial College London · GBUniversity of Cambridge · GBKing's College London · GBNello Carrara Institute of Applied Physics · ITUniversity of Turin · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aberrant aggregation of α-synuclein (αS) into amyloid fibrils is associated with a range of highly debilitating neurodegenerative conditions, including Parkinson's disease. Although the structural properties of mature amyloids of αS are currently understood, the nature of transient protofilaments and fibrils that appear during αS aggregation remains elusive. Using solid-state nuclear magnetic resonance (ssNMR), cryogenic electron microscopy (cryo-EM), and biophysical methods, we here characterized intermediate amyloid fibrils of αS forming during the aggregation from liquid-like spherical condensates to mature amyloids adopting the structure of pathologically observed aggregates. These transient amyloid intermediates, which induce significant levels of cytotoxicity when incubated with neuronal cells, were found to be stabilized by a small core in an antiparallel β-sheet conformation, with a disordered N-terminal region of the protein remaining available to mediate membrane binding. In contrast, mature amyloids that subsequently appear during the aggregation showed different structural and biological properties, including low levels of cytotoxicity, a rearranged structured core embedding also the N-terminal region, and a reduced propensity to interact with the membrane. The characterization of these two fibrillar forms of αS, and the use of antibodies and designed mutants, enabled us to clarify the role of critical structural elements endowing intermediate amyloid species with the ability to interact with membranes and induce cytotoxicity.

Indexed as

Neurodegenerative DiseasesParkinson Diseasealpha-SynucleinAmyloidHumansProtein Conformation, beta-Strandalpha-SynucleinAmyloid

Identifiers

PMID38567991
PMCPMC11027145
OpenAlexW4393855044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.